Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

28.50
Delayed Data
As of May 26
 -0.21 / -0.73%
Today’s Change
28.06
Today|||52-Week Range
56.44
-21.38%
Year-to-Date
TEVA Regular Dividend: TEVA will begin trading ex-dividend on 06/01/17 with a $0.34 dividend payable to shareholders of record as of 06/05/17.

Today’s Trading

Previous close28.71
Today’s open28.70
Day’s range28.25 - 28.71
Volume6,215,511
Average volume (3 months)8,978,806
Market cap$28.9B
Dividend yield4.77%
Data as of 4:02pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-96.18%
Earnings growth (this year)-6.97%
Earnings growth (next 5 years)+0.35%
Revenue growth (last year)+12.01%
P/E ratio1,425.0
Price/Sales1.59
Price/Book0.97

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-0.04-0.11%
OASMOasmia Pharmaceutica...0.000.00%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$1.15
Annual revenue (last year)$22.0B
Annual profit (last year)$330.0M
Net profit margin1.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
Yitzhak Peterburg
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts